A Harsher Look at California's Stem Cell Program: No More Cash Without Changes
By David Jensen, California Stem Cell Report [cites CGS' Pete Shanks] | 08. 23. 2018
California's $3 billion stem cell experiment received a host of accolades last week at a state legislative hearing, but one strong, critical voice was not heard in the proceedings.
That came from the Biopolitical Times, a blog operated by the Center for Genetics and Society of Berkeley, a longtime foe of the agency.
In a piece written by Pete Shanks, the agency was taken to task for a number of reasons. And he argued that it should not receive additional funds as it is presently constituted.
Shanks wrote,
"At one time, CIRM had a deserved reputation for funding buildings , some of them at private universities, and was heavily criticized for that, but the $270 million “major facilities” budget approved in 2008 has all been spent. Some of the conflict of interest scandals are largely in the past, though ripples persist , and some of the institutional ones remain; several universities that receive large grants are still represented on the board . But there has been a new regime in place (“CIRM 2.0”) for several...
Related Articles
By Usha Lee McFarling, Los Angeles Times | 01.23.2019
In case you haven’t noticed, stem cell clinics are popping up everywhere. There are hundreds across the country, especially in California. The clinics peddle “vegan stem cell facials” or “stem cell vaginal rejuvenations” and claim the miracle cells can...
By Max Levy, Vox | 01.13.2019
Inside Mark Berman’s clinic in Rancho Mirage, California, is a sign he’s obliged by law to post. It reads “Not FDA Approved.”
Patients who come here to the California Stem Cell Treatment Center can get treatments for ailments ranging from...
By Nishakanthi Gopalan et al., Biotechnology Law Report | 10.09.2018
Abstract
Stem cell (SC) technology has spurred many debates among experts which highlight both the deficiency of current regulation and the growing need for better oversight. The benefit of better regulating SC technology is easily understood by studying the variety...
By Gina Kolata, The New York Times | 10.29.2018
For Dr. Piero Anversa, the fall from scientific grace has been long, and the landing hard.
Researchers worldwide once hailed his research as revolutionary, promising the seemingly impossible: a way to grow new heart cells to replace those lost in...
